US7375198B2
(en)
*
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
US6475721B2
(en)
|
1995-03-04 |
2002-11-05 |
Boston Probes, Inc. |
Sequence specific detection of nucleic acids using a solid carrier bound with nucleic acid analog probes
|
GB9507238D0
(en)
*
|
1995-04-07 |
1995-05-31 |
Isis Innovation |
Detecting dna sequence variations
|
US20020150921A1
(en)
*
|
1996-02-09 |
2002-10-17 |
Francis Barany |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US6852487B1
(en)
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
AU2320597A
(en)
|
1996-03-19 |
1997-10-10 |
Molecular Tool, Inc. |
Method for determining the nucleotide sequence of a polynucleotide
|
EP1736554B1
(de)
*
|
1996-05-29 |
2013-10-09 |
Cornell Research Foundation, Inc. |
Bestimmung von Unterschieden in der Nukleinsäuresequenz mittels einer Kombination von Ligasebestimmung und Polymerasekettenreaktion
|
DE69736667T2
(de)
*
|
1996-07-16 |
2007-09-06 |
Gen-Probe Inc., San Diego |
Verfahren zum nachweis und amplifikation von nukleinsäuresequenzen unter verbrauch von modifizierten oligonukleotiden mit erhöhter zielschmelztemperatur (tm)
|
US7070925B1
(en)
*
|
1996-07-16 |
2006-07-04 |
Gen-Probe Incorporated |
Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
|
US6361940B1
(en)
|
1996-09-24 |
2002-03-26 |
Qiagen Genomics, Inc. |
Compositions and methods for enhancing hybridization and priming specificity
|
WO1998029736A1
(en)
*
|
1996-12-31 |
1998-07-09 |
Genometrix Incorporated |
Multiplexed molecular analysis apparatus and method
|
SE522077C2
(sv)
|
1997-09-05 |
2004-01-13 |
Lightup Technologies Ab |
Förfarande att välja sekvens hos sond för nukleinsyrahybridisering
|
US6518017B1
(en)
*
|
1997-10-02 |
2003-02-11 |
Oasis Biosciences Incorporated |
Combinatorial antisense library
|
US6723560B2
(en)
*
|
1998-10-08 |
2004-04-20 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US6989270B1
(en)
|
1997-10-17 |
2006-01-24 |
Mayo Foundation For Medical Education And Research |
Using polyamide nucleic acid oligomers to engender a biological response
|
US20100105572A1
(en)
*
|
1997-12-19 |
2010-04-29 |
Kris Richard M |
High throughput assay system
|
US20030039967A1
(en)
*
|
1997-12-19 |
2003-02-27 |
Kris Richard M. |
High throughput assay system using mass spectrometry
|
US20030096232A1
(en)
*
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
US6087102A
(en)
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
US6289229B1
(en)
|
1998-01-20 |
2001-09-11 |
Scimed Life Systems, Inc. |
Readable probe array for in vivo use
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
US6077673A
(en)
*
|
1998-03-31 |
2000-06-20 |
Clontech Laboratories, Inc. |
Mouse arrays and kits comprising the same
|
EP1068356B8
(de)
*
|
1998-04-03 |
2007-01-03 |
Adnexus Therapeutics, Inc. |
Adressierbare protein arrays
|
US7715989B2
(en)
*
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US6683173B2
(en)
*
|
1998-04-03 |
2004-01-27 |
Epoch Biosciences, Inc. |
Tm leveling methods
|
US7875440B2
(en)
|
1998-05-01 |
2011-01-25 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6780591B2
(en)
|
1998-05-01 |
2004-08-24 |
Arizona Board Of Regents |
Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
|
US6979728B2
(en)
|
1998-05-04 |
2005-12-27 |
Baylor College Of Medicine |
Articles of manufacture and methods for array based analysis of biological molecules
|
DE69941333D1
(de)
*
|
1998-07-02 |
2009-10-08 |
Gen Probe Inc |
Molekulare fackeln
|
US6222030B1
(en)
*
|
1998-08-03 |
2001-04-24 |
Agilent Technologies, Inc. |
Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
|
US6461812B2
(en)
|
1998-09-09 |
2002-10-08 |
Agilent Technologies, Inc. |
Method and multiple reservoir apparatus for fabrication of biomolecular arrays
|
US6475440B1
(en)
|
1998-09-16 |
2002-11-05 |
Clontech Laboratories, Inc. |
Applicator for use in deposition of fluid samples onto a substrate surface
|
US6087112A
(en)
|
1998-12-30 |
2000-07-11 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6506594B1
(en)
*
|
1999-03-19 |
2003-01-14 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
WO2000070093A1
(en)
*
|
1999-05-13 |
2000-11-23 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6818395B1
(en)
|
1999-06-28 |
2004-11-16 |
California Institute Of Technology |
Methods and apparatus for analyzing polynucleotide sequences
|
KR100379411B1
(ko)
*
|
1999-06-28 |
2003-04-10 |
엘지전자 주식회사 |
바이오칩 및 그의 생체 물질 패터닝 및 측정 방법
|
US6346423B1
(en)
|
1999-07-16 |
2002-02-12 |
Agilent Technologies, Inc. |
Methods and compositions for producing biopolymeric arrays
|
EP1072679A3
(de)
*
|
1999-07-20 |
2002-07-31 |
Agilent Technologies, Inc. (a Delaware corporation) |
Methode zur Herstelung von Nucleinsäuremolekülen mit einer reduzierten Sekundärstruktur
|
US20050118618A1
(en)
*
|
1999-08-30 |
2005-06-02 |
Dale Roderic M. |
Method for detecting nucleic acid sequences
|
US7244559B2
(en)
|
1999-09-16 |
2007-07-17 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
US7211390B2
(en)
|
1999-09-16 |
2007-05-01 |
454 Life Sciences Corporation |
Method of sequencing a nucleic acid
|
WO2001023620A2
(en)
*
|
1999-09-29 |
2001-04-05 |
Oligos Etc. Inc. |
Arrays with modified oligonucleotide and polynucleotide compositions
|
US6844151B1
(en)
|
1999-09-29 |
2005-01-18 |
Oligos Etc. Inc. |
Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
US6171797B1
(en)
|
1999-10-20 |
2001-01-09 |
Agilent Technologies Inc. |
Methods of making polymeric arrays
|
US6958225B2
(en)
|
1999-10-27 |
2005-10-25 |
Affymetrix, Inc. |
Complexity management of genomic DNA
|
US6660845B1
(en)
*
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
WO2001038585A2
(en)
*
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
|
EP1111069A1
(de)
*
|
1999-12-22 |
2001-06-27 |
BioChip Technologies GmbH |
Modifizierte Nukleinsäuren und deren Verwendung
|
US6800439B1
(en)
|
2000-01-06 |
2004-10-05 |
Affymetrix, Inc. |
Methods for improved array preparation
|
AU9256001A
(en)
*
|
2000-01-28 |
2001-12-17 |
Lexicon Genetics Incorporated |
Novel human enzymes and polynucleotides encoding the same
|
US6489466B2
(en)
*
|
2000-01-28 |
2002-12-03 |
Linden Technologies, Inc. |
C-3′ protected monomeric nucleotides and synthesis of oligonucleotides on solid support
|
US6833450B1
(en)
|
2000-03-17 |
2004-12-21 |
Affymetrix, Inc. |
Phosphite ester oxidation in nucleic acid array preparation
|
US6806361B1
(en)
|
2000-03-17 |
2004-10-19 |
Affymetrix, Inc. |
Methods of enhancing functional performance of nucleic acid arrays
|
AU2001249701A1
(en)
*
|
2000-03-31 |
2001-10-15 |
The Regents Of The University Of California |
Dna analysis software
|
AU2001293366A1
(en)
|
2000-04-14 |
2001-10-30 |
Cornell Research Foundation, Inc. |
Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
|
US20020028455A1
(en)
*
|
2000-05-03 |
2002-03-07 |
Laibinis Paul E. |
Methods and reagents for assembling molecules on solid supports
|
WO2001090417A2
(en)
|
2000-05-19 |
2001-11-29 |
Eragen Biosciences, Inc. |
Materials and methods for detection of nucleic acids
|
US20020120409A1
(en)
*
|
2000-05-19 |
2002-08-29 |
Affymetrix, Inc. |
Methods for gene expression analysis
|
US6977161B2
(en)
|
2000-10-14 |
2005-12-20 |
Eragen Biosciences, Inc. |
Solid support assay systems and methods utilizing non-standard bases
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EP1294735A2
(de)
|
2000-05-26 |
2003-03-26 |
Novirio Pharmaceuticals Limited |
Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren
|
US7005259B1
(en)
|
2000-06-01 |
2006-02-28 |
Affymetrix, Inc. |
Methods for array preparation using substrate rotation
|
US7135565B2
(en)
|
2000-07-28 |
2006-11-14 |
Agilent Technologies, Inc. |
Synthesis of polynucleotides using combined oxidation/deprotection chemistry
|
WO2002012263A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Roche Diagnostics Gmbh |
Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
|
US20030082605A1
(en)
*
|
2000-09-06 |
2003-05-01 |
Hodge Timothy A. |
Genomic DNA detection method and system thereof
|
US20030087286A1
(en)
*
|
2000-09-06 |
2003-05-08 |
Hodge Timothy A. |
Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
|
US20050272085A1
(en)
*
|
2000-09-06 |
2005-12-08 |
Hodge Timothy A |
Methods for forensic and congenic screening
|
US20050239125A1
(en)
*
|
2000-09-06 |
2005-10-27 |
Hodge Timothy A |
Methods for genotype screening
|
EP1978110B1
(de)
*
|
2000-09-06 |
2010-05-26 |
Transnetyx, Inc. |
Computer-basiertes Verfahren und System zum Screenen von genomischer DNS
|
US7494817B2
(en)
*
|
2000-09-06 |
2009-02-24 |
Transnet Yx, Inc. |
Methods for genotype screening using magnetic particles
|
US20050266494A1
(en)
*
|
2000-09-06 |
2005-12-01 |
Hodge Timothy A |
System and method for computer network ordering of biological testing
|
US20040185464A1
(en)
*
|
2000-09-15 |
2004-09-23 |
Kris Richard M. |
High throughput assay system
|
CN100385013C
(zh)
*
|
2000-10-14 |
2008-04-30 |
伊拉根生物科学公司 |
使用非标准碱基的固相支持体分析系统和方法
|
US6849409B2
(en)
|
2000-10-16 |
2005-02-01 |
Axxima Pharmaceuticals Ag |
Cellular kinases involved in Cytomegalovirus infection and their inhibition
|
WO2002078619A2
(en)
*
|
2001-02-13 |
2002-10-10 |
University Of Rochester |
Alkynylated single-strand oligonucleotide and uses thereof
|
DE10112348A1
(de)
*
|
2001-03-13 |
2002-10-02 |
Antje Roetger |
Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen
|
US20040038206A1
(en)
*
|
2001-03-14 |
2004-02-26 |
Jia Zhang |
Method for high throughput assay of genetic analysis
|
WO2002074979A2
(en)
*
|
2001-03-20 |
2002-09-26 |
Ortho-Clinical Diagnostics, Inc. |
Expression profiles and methods of use
|
WO2002083839A2
(en)
*
|
2001-03-30 |
2002-10-24 |
Amersham Biosciences Ab |
P450 single nucleotide polymorphism biochip analysis
|
EP1251183A3
(de)
*
|
2001-04-18 |
2003-12-10 |
Exiqon A/S |
Verbesserte Helfersonden zur Detektion einer Zielsequenz mittels Fangoligonukleotid
|
EP2423335B1
(de)
|
2001-06-21 |
2014-05-14 |
Dynavax Technologies Corporation |
Chimäre immunmodulierende Verbindungen und Verwendungsverfahren dafür
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US7264964B2
(en)
*
|
2001-06-22 |
2007-09-04 |
Ceres, Inc. |
Chimeric histone acetyltransferase polypeptides
|
US20050147984A1
(en)
*
|
2001-08-31 |
2005-07-07 |
Clondiag Chip Technologies Gmbh |
Interaction detection on several probe arrays
|
US20030105320A1
(en)
*
|
2001-08-31 |
2003-06-05 |
Becker Michael M. |
Affinity-shifted probes for quantifying analyte polynucleotides
|
DE10142643A1
(de)
*
|
2001-08-31 |
2003-04-24 |
Clondiag Chip Tech Gmbh |
Detektion von Wechselwirkungen auf Sonden-Arrays
|
KR100809679B1
(ko)
*
|
2001-09-01 |
2008-03-06 |
삼성전자주식회사 |
혼성화된 핵산의 검출 및 신호 증폭 방법
|
US20060014186A1
(en)
*
|
2001-09-04 |
2006-01-19 |
Hodge Timothy A |
Methods for genotype screening of a strain disposed on an adsorbent carrier
|
DE10152925A1
(de)
*
|
2001-10-26 |
2003-05-08 |
Febit Ag |
Asymmetrische Sonden
|
US6858720B2
(en)
|
2001-10-31 |
2005-02-22 |
Agilent Technologies, Inc. |
Method of synthesizing polynucleotides using ionic liquids
|
US6852850B2
(en)
|
2001-10-31 |
2005-02-08 |
Agilent Technologies, Inc. |
Use of ionic liquids for fabrication of polynucleotide arrays
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20110151438A9
(en)
|
2001-11-19 |
2011-06-23 |
Affymetrix, Inc. |
Methods of Analysis of Methylation
|
US20030211526A1
(en)
*
|
2002-02-15 |
2003-11-13 |
Jyh-Lyh Juang |
Cross-species nucleic acid probes
|
US20030162178A1
(en)
*
|
2002-02-25 |
2003-08-28 |
O'hagan David |
Variable microarray and methods of detecting one or more anlaytes in a sample
|
AU2003220159A1
(en)
*
|
2002-03-08 |
2003-09-22 |
Spectral Genomics, Inc. |
Articles of manufacture and methods for making hydrophobic derivatized arrays
|
US6916621B2
(en)
|
2002-03-27 |
2005-07-12 |
Spectral Genomics, Inc. |
Methods for array-based comparitive binding assays
|
US7687256B2
(en)
*
|
2002-04-11 |
2010-03-30 |
Spire Corporation |
Surface activated biochip
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
WO2003093296A2
(en)
*
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040014957A1
(en)
*
|
2002-05-24 |
2004-01-22 |
Anne Eldrup |
Oligonucleotides having modified nucleoside units
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
KR20050035194A
(ko)
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
|
FR2842827B1
(fr)
*
|
2002-07-26 |
2004-10-22 |
Biocortech |
NOUVELLE METHODE D'ANALYSE D'ACIDE NUCLEIQUE ET SON UTILISATION POUR EVALUER LE DEGRE D'EDITION DE L'ARNm DU RECEPTEUR 5-HT2c
|
US7164533B2
(en)
|
2003-01-22 |
2007-01-16 |
Cyvera Corporation |
Hybrid random bead/chip based microarray
|
US7901630B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Diffraction grating-based encoded microparticle assay stick
|
US7872804B2
(en)
|
2002-08-20 |
2011-01-18 |
Illumina, Inc. |
Encoded particle having a grating with variations in the refractive index
|
US7900836B2
(en)
|
2002-08-20 |
2011-03-08 |
Illumina, Inc. |
Optical reader system for substrates having an optically readable code
|
US7508608B2
(en)
|
2004-11-17 |
2009-03-24 |
Illumina, Inc. |
Lithographically fabricated holographic optical identification element
|
US7923260B2
(en)
|
2002-08-20 |
2011-04-12 |
Illumina, Inc. |
Method of reading encoded particles
|
WO2004024314A2
(en)
*
|
2002-09-11 |
2004-03-25 |
Exiqon A/S |
A population of nucleic acids including a subpopulation of lna oligomers
|
US20100255603A9
(en)
|
2002-09-12 |
2010-10-07 |
Putnam Martin A |
Method and apparatus for aligning microbeads in order to interrogate the same
|
US7092160B2
(en)
|
2002-09-12 |
2006-08-15 |
Illumina, Inc. |
Method of manufacturing of diffraction grating-based optical identification element
|
US20040219565A1
(en)
*
|
2002-10-21 |
2004-11-04 |
Sakari Kauppinen |
Oligonucleotides useful for detecting and analyzing nucleic acids of interest
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
JP2006512928A
(ja)
*
|
2002-11-15 |
2006-04-20 |
ジェン−プローブ・インコーポレーテッド |
炭疽菌(Bacillusanthracis)核酸を検出するためのアッセイおよび組成物
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
US7598373B2
(en)
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
ATE417129T1
(de)
|
2003-01-17 |
2008-12-15 |
Eragen Biosciences Inc |
Nukleinsäureamplifikation mit nichtstandardbasen
|
EP1604022A2
(de)
*
|
2003-03-06 |
2005-12-14 |
Oligo Engine, Inc. |
Veränderung der genexpression mit dns-rns hybriden
|
CA2521127C
(en)
|
2003-04-01 |
2014-05-27 |
Eragen Biosciences, Inc. |
Polymerase inhibitor and method of using same
|
CA2463719A1
(en)
*
|
2003-04-05 |
2004-10-05 |
F. Hoffmann-La Roche Ag |
Nucleotide analogs with six membered rings
|
US20040219532A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Sampson Jeffrey R. |
Internal references measurements
|
JP2004337042A
(ja)
*
|
2003-05-14 |
2004-12-02 |
Canon Inc |
核酸アレイ
|
EP2345661A1
(de)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modifizierte fluorinierte Nukleosidanaloga
|
US7799525B2
(en)
*
|
2003-06-17 |
2010-09-21 |
Human Genetic Signatures Pty Ltd. |
Methods for genome amplification
|
US20050064462A1
(en)
*
|
2003-06-17 |
2005-03-24 |
Bernd Stein |
Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
|
US20040259100A1
(en)
|
2003-06-20 |
2004-12-23 |
Illumina, Inc. |
Methods and compositions for whole genome amplification and genotyping
|
US7642064B2
(en)
|
2003-06-24 |
2010-01-05 |
Ventana Medical Systems, Inc. |
Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
|
WO2005024053A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Human Genetic Signatures Pty Ltd |
Nucleic acid detection assay
|
GB0324851D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Expresson Biosystems Ltd |
Short biological polymers on solid supports
|
WO2005040163A1
(en)
*
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
US7169560B2
(en)
|
2003-11-12 |
2007-01-30 |
Helicos Biosciences Corporation |
Short cycle methods for sequencing polynucleotides
|
US7433123B2
(en)
|
2004-02-19 |
2008-10-07 |
Illumina, Inc. |
Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
|
US7981604B2
(en)
|
2004-02-19 |
2011-07-19 |
California Institute Of Technology |
Methods and kits for analyzing polynucleotide sequences
|
US8168777B2
(en)
|
2004-04-29 |
2012-05-01 |
Human Genetic Signatures Pty. Ltd. |
Bisulphite reagent treatment of nucleic acid
|
US7702466B1
(en)
|
2004-06-29 |
2010-04-20 |
Illumina, Inc. |
Systems and methods for selection of nucleic acid sequence probes
|
JP4476050B2
(ja)
*
|
2004-06-30 |
2010-06-09 |
株式会社ニデック |
視野計
|
DE602005020943D1
(de)
|
2004-07-01 |
2010-06-10 |
Gen Probe Inc |
Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
WO2006020363A2
(en)
|
2004-07-21 |
2006-02-23 |
Illumina, Inc. |
Method and apparatus for drug product tracking using encoded optical identification elements
|
US20080199480A1
(en)
*
|
2004-07-22 |
2008-08-21 |
Sequenom, Inc. |
Methods for Identifying Risk of Type II Diabetes and Treatments Thereof
|
AU2005285045B2
(en)
|
2004-09-14 |
2011-10-13 |
Gilead Pharmasset Llc |
Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
EP1645640B1
(de)
|
2004-10-05 |
2013-08-21 |
Affymetrix, Inc. |
Verfahren zur Detektion von chromosomalen Translokationen
|
DE602005019791D1
(de)
|
2004-11-16 |
2010-04-15 |
Illumina Inc |
Verfahren und vorrichtung zum lesen von kodierten mikrokugeln
|
NZ555620A
(en)
*
|
2004-12-03 |
2008-08-29 |
Human Genetic Signatures Pty |
Methods for simplifying microbial nucleic acids by chemical modification of cytosines
|
US20090029346A1
(en)
*
|
2004-12-23 |
2009-01-29 |
Human Genetic Signatures Pty., Ltd. |
Detection of human papilloma virus
|
EP1841866B1
(de)
*
|
2005-01-25 |
2009-04-22 |
Sky Genetics, Inc. |
Nukleinsäuren für die apoptose von krebszellen
|
US20060183893A1
(en)
*
|
2005-01-25 |
2006-08-17 |
North Don A |
Nucleic acids for apoptosis of cancer cells
|
WO2006089045A2
(en)
|
2005-02-18 |
2006-08-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
|
EP1856298B1
(de)
*
|
2005-02-18 |
2017-09-27 |
Monogram BioSciences, Inc. |
Verfahren und zusammensetzungen zur bestimmung der suszeptibilität für anti-hiv-mittel und des hiv-replikationsvermögens
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
WO2006101913A2
(en)
|
2005-03-18 |
2006-09-28 |
Eragen Biosciences, Inc. |
Methods for detecting multiple species and subspecies of neiserria
|
AU2006251866B2
(en)
*
|
2005-05-26 |
2007-11-29 |
Human Genetic Signatures Pty Ltd |
Isothermal strand displacement amplification using primers containing a non-regular base
|
EP2458018A3
(de)
|
2005-05-27 |
2012-07-25 |
Monogram BioSciences, Inc. |
Verfahren und Zusammensetzungen zum Bestimmen der HIV-1-Beständigkeit gegenüber Proteasehemmern
|
US9506121B2
(en)
*
|
2005-06-06 |
2016-11-29 |
Monogram Biosciences, Inc. |
Methods for determining resistance or susceptibility to HIV entry inhibitors
|
US8071284B2
(en)
*
|
2005-06-06 |
2011-12-06 |
Monogram Biosciences, Inc. |
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
|
CA2919210C
(en)
|
2005-06-07 |
2019-03-05 |
Luminex Corporation |
Methods for detection and typing of nucleic acids
|
JP5331476B2
(ja)
|
2005-06-15 |
2013-10-30 |
カリダ・ジェノミックス・インコーポレイテッド |
遺伝子解析および化学解析用の単分子アレイ
|
US20060292585A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
WO2007015578A1
(ja)
*
|
2005-08-02 |
2007-02-08 |
Eisai R & D Management Co., Ltd. |
血管新生阻害物質の効果を検定する方法
|
US7666593B2
(en)
|
2005-08-26 |
2010-02-23 |
Helicos Biosciences Corporation |
Single molecule sequencing of captured nucleic acids
|
US8343738B2
(en)
*
|
2005-09-14 |
2013-01-01 |
Human Genetic Signatures Pty. Ltd. |
Assay for screening for potential cervical cancer
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
WO2007052849A1
(ja)
|
2005-11-07 |
2007-05-10 |
Eisai R & D Management Co., Ltd. |
血管新生阻害物質とc-kitキナーゼ阻害物質との併用
|
EP1976382B1
(de)
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Verfahren zur herstellung eines synthetischen zwischenprodukts für die herstellung von verzweigten nukleosiden
|
TW200745556A
(en)
*
|
2006-01-24 |
2007-12-16 |
Ind Tech Res Inst |
Biomarkers for liver fibrotic injury
|
US20080045471A1
(en)
*
|
2006-03-27 |
2008-02-21 |
North Don A |
Nucleic Acids For Apoptosis Of Cancer Cells
|
US7901882B2
(en)
|
2006-03-31 |
2011-03-08 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
US7830575B2
(en)
|
2006-04-10 |
2010-11-09 |
Illumina, Inc. |
Optical scanner with improved scan time
|
CA2652442C
(en)
|
2006-05-18 |
2014-12-09 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
EP2602321B1
(de)
|
2006-05-31 |
2017-08-23 |
Sequenom, Inc. |
Verfahren und Zusammensetzungen zur Nukleinsäureextraktion und -verstärkung aus einer Probe
|
US20080050738A1
(en)
*
|
2006-05-31 |
2008-02-28 |
Human Genetic Signatures Pty Ltd. |
Detection of target nucleic acid
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
KR101472600B1
(ko)
|
2006-08-28 |
2014-12-15 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
미분화형 위암에 대한 항종양제
|
EP2092074A4
(de)
|
2006-11-02 |
2010-06-09 |
Univ Yale |
Beurteilung der befruchtungsfähigkeit von eizellen
|
EP2099935B1
(de)
*
|
2006-11-30 |
2014-02-26 |
The Regents Of The University Of California |
Array für den nachweis von mikroben
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
DE102006062089A1
(de)
|
2006-12-29 |
2008-07-03 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
DE102007018833A1
(de)
|
2007-04-20 |
2008-10-23 |
Febit Holding Gmbh |
Verbesserte molekularbiologische Prozessanlage
|
CA2676796C
(en)
|
2007-01-29 |
2016-02-23 |
Eisai R & D Management Co., Ltd. |
Composition for treatment of undifferentiated gastric cancer
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
US9581595B2
(en)
|
2007-02-26 |
2017-02-28 |
Laboratory Corporation Of America Holdings |
Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
|
US20110189663A1
(en)
|
2007-03-05 |
2011-08-04 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008113111A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Human Genetic Signatures Pty Ltd |
Assay for gene expression
|
AU2008230813B2
(en)
|
2007-03-26 |
2014-01-30 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2617837A3
(de)
|
2007-06-08 |
2013-10-23 |
Biogen Idec MA Inc. |
Biomarker zur Vorhersage des Ansprechens oder Nichtansprechens auf Anti-TNF
|
US9404150B2
(en)
|
2007-08-29 |
2016-08-02 |
Sequenom, Inc. |
Methods and compositions for universal size-specific PCR
|
WO2009060945A1
(ja)
*
|
2007-11-09 |
2009-05-14 |
Eisai R & D Management Co., Ltd. |
血管新生阻害物質と抗腫瘍性白金錯体との併用
|
EP2215250B1
(de)
|
2007-11-27 |
2013-02-27 |
Human Genetic Signatures Pty Ltd |
Enzyme zur amplifikation und zum kopieren bisulphit-modifizierter nukleinsäuren
|
US20110003700A1
(en)
*
|
2007-12-20 |
2011-01-06 |
Human Genetic Signatures Pty Ltd. |
Elimination of contaminants associated with nucleic acid amplification
|
EP2271772B1
(de)
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung
|
US8206926B2
(en)
|
2008-03-26 |
2012-06-26 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
WO2009121012A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Greene, Tweed Of Delaware, Inc. |
Inert substrate-bonded fluoroelastometer components and related methods
|
WO2009121021A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Life Technologies Corporation |
Degradable arrays for preventing reuse
|
US20090269746A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Gil Atzmon |
Microsequencer-whole genome sequencer
|
EP2806037B1
(de)
*
|
2008-05-13 |
2016-09-21 |
Gen-Probe Incorporated |
Inaktivierbare Target-Capture-Oligomere zur Verwendung bei der selektiven Hybridisierung und beim Fangen von Zielnukleinsäuresequenzen
|
WO2010096036A2
(en)
|
2008-05-14 |
2010-08-26 |
Millennium Pharmaceuticals, Inc. |
Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US8470164B2
(en)
|
2008-06-25 |
2013-06-25 |
Life Technologies Corporation |
Methods and apparatus for measuring analytes using large scale FET arrays
|
JP5586607B2
(ja)
|
2008-08-29 |
2014-09-10 |
ヤンセン バイオテツク,インコーポレーテツド |
20個の遺伝子パネルを用いて潰瘍性大腸炎及び関連疾患を評価し治療するためのマーカー及び方法
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2352998A4
(de)
|
2008-11-07 |
2011-09-21 |
Centocor Ortho Biotech Inc |
Marker und verfahren zur untersuchung und behandlung von lichtreizempfindlichen lupus-patienten
|
EP2367958B1
(de)
*
|
2008-11-25 |
2017-08-23 |
Gen-Probe Incorporated |
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ERKENNUNG VON sRNA UND IHRE VERWENDUNG
|
SG172361A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside analogs
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
AU2009329872B2
(en)
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
EP2414545B1
(de)
|
2009-04-03 |
2017-01-11 |
Sequenom, Inc. |
Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8628924B2
(en)
|
2009-07-21 |
2014-01-14 |
Gen-Probe Incorporated |
Methods and compositions for quantitative amplification and detection over a wide dynamic range
|
CN102639712A
(zh)
|
2009-10-23 |
2012-08-15 |
卢米耐克斯公司 |
用于提高反应特异性的具有非标准碱基的扩增引物
|
WO2011087760A2
(en)
|
2009-12-22 |
2011-07-21 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
WO2011079280A2
(en)
|
2009-12-23 |
2011-06-30 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a canine
|
EP2752422B1
(de)
|
2010-03-31 |
2017-08-16 |
Gilead Pharmasset LLC |
Stereoselektive synthese von phosphorhaltigen wirkstoffen
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
WO2011159942A1
(en)
|
2010-06-18 |
2011-12-22 |
Illumina, Inc. |
Conformational probes and methods for sequencing nucleic acids
|
EP2586443B1
(de)
|
2010-06-25 |
2016-03-16 |
Eisai R&D Management Co., Ltd. |
Antitumorwirkstoff mit verbindungen mit kinasehemmungswirkung in kombination
|
NZ607996A
(en)
|
2010-09-22 |
2014-07-25 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
CA2819230A1
(en)
|
2010-10-28 |
2012-05-03 |
Yale University |
Methods and compositions for assessing and treating cancer
|
EP2643470B1
(de)
|
2010-11-24 |
2016-02-03 |
Yale University |
Zusammensetzungen und verfahren zur behandlung von ischämieschaden mit d-dt
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
JP5808825B2
(ja)
|
2011-02-24 |
2015-11-10 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
ネコの腎障害を診断および治療する組成物および方法
|
CA2828946C
(en)
|
2011-04-18 |
2016-06-21 |
Eisai R&D Management Co., Ltd. |
Therapeutic agent for tumor
|
EP2699903B1
(de)
|
2011-04-20 |
2018-07-18 |
Life Technologies Corporation |
Verfahren, zusammensetzungen und systeme zur probenablagerung
|
EP3378954B1
(de)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantifizierung einer minderheitsvariante einer nukleinsäure
|
ES2705950T3
(es)
|
2011-06-03 |
2019-03-27 |
Eisai R&D Man Co Ltd |
Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
|
EP2721175B1
(de)
|
2011-06-15 |
2015-09-16 |
Hill's Pet Nutrition, Inc. |
Zusammensetzungen und verfahren zur diagnose und überwachung von schilddrüsenüberfunktion bei der katze
|
CN103874766B
(zh)
|
2011-09-07 |
2017-07-18 |
人类遗传标记控股有限公司 |
分子检测测定
|
JP6238900B2
(ja)
|
2011-10-28 |
2017-11-29 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
Nae阻害物質に対する応答のバイオマーカー
|
JP6286358B2
(ja)
|
2011-11-11 |
2018-02-28 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤に応答するバイオマーカー
|
WO2013071142A1
(en)
|
2011-11-11 |
2013-05-16 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
WO2013082448A1
(en)
|
2011-12-01 |
2013-06-06 |
University Of Kansas |
Methods for detecting trisomy 21
|
WO2013087789A1
(en)
|
2011-12-13 |
2013-06-20 |
Glykos Finland Ltd. |
Antibody isoform arrays and methods thereof
|
CN104039823A
(zh)
|
2011-12-19 |
2014-09-10 |
希尔氏宠物营养品公司 |
用于诊断和治疗伴侣动物的甲状腺机能亢进的组合物和方法
|
EP2794630A4
(de)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
Substituierte phosphorthioat-nukleotidanaloga
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9012022B2
(en)
|
2012-06-08 |
2015-04-21 |
Illumina, Inc. |
Polymer coatings
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US10066025B2
(en)
|
2012-07-16 |
2018-09-04 |
Yale University |
Compositions and methods for detecting, treating and preventing diseases and disorders
|
WO2014055543A2
(en)
|
2012-10-01 |
2014-04-10 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods to predict response to inhibitors and uses thereof
|
MX363243B
(es)
|
2012-11-28 |
2019-03-14 |
Merck Sharp & Dohme |
Composiciones para tratar cáncer y usos de dichas composiciones.
|
CN104755463A
(zh)
|
2012-12-21 |
2015-07-01 |
卫材R&D管理有限公司 |
非晶态形式的喹啉衍生物及其生产方法
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
WO2014126965A2
(en)
|
2013-02-13 |
2014-08-21 |
Yale University |
Compositions and methods for treating pathological calcification and ossification
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
DK2970356T3
(en)
|
2013-03-15 |
2018-08-27 |
Illumina Cambridge Ltd |
Modified nucleosides or nucleotides
|
MX368099B
(es)
|
2013-05-14 |
2019-09-19 |
Eisai R&D Man Co Ltd |
Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
|
CN109734946B
(zh)
|
2013-07-01 |
2021-10-26 |
Illumina公司 |
无催化剂的表面官能化和聚合物接枝
|
US10093978B2
(en)
|
2013-08-12 |
2018-10-09 |
Genentech, Inc. |
Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
US10144015B2
(en)
|
2013-11-11 |
2018-12-04 |
Life Technologies Corporation |
Rotor plate and bucket assembly and method for using same
|
EP3084003A4
(de)
|
2013-12-17 |
2017-07-19 |
Merck Sharp & Dohme Corp. |
Ifn-gamma-gensignaturbiomarker der tumorreaktion auf pd-1 antagonisten
|
CN114089597A
(zh)
|
2013-12-19 |
2022-02-25 |
Illumina公司 |
包括纳米图案化表面的基底及其制备方法
|
TW202239429A
(zh)
|
2014-02-08 |
2022-10-16 |
美商建南德克公司 |
治療阿茲海默症之方法
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
US20170107499A1
(en)
|
2014-05-16 |
2017-04-20 |
Yale University |
Compositions and Methods for Treating and Preventing Pancreatitis, Renal Injury and Cancer
|
GB201414098D0
(en)
|
2014-08-08 |
2014-09-24 |
Illumina Cambridge Ltd |
Modified nucleotide linkers
|
WO2016026924A1
(en)
|
2014-08-21 |
2016-02-25 |
Illumina Cambridge Limited |
Reversible surface functionalization
|
JO3783B1
(ar)
|
2014-08-28 |
2021-01-31 |
Eisai R&D Man Co Ltd |
مشتق كوينولين عالي النقاء وطريقة لإنتاجه
|
SI3212684T1
(sl)
|
2014-10-31 |
2020-04-30 |
Illumina Cambridge Limited |
Polimeri in DNK kopolimer premazi
|
JP2018505658A
(ja)
|
2014-12-09 |
2018-03-01 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
Pd−1アンタゴニストに対する応答の遺伝子シグネチャーバイオマーカーを得るための系および方法
|
EP3250588A1
(de)
|
2015-01-29 |
2017-12-06 |
Board of Trustees of Michigan State University |
Kryptische polypeptide und verwendungen davon
|
DK3263106T3
(da)
|
2015-02-25 |
2024-01-08 |
Eisai R&D Man Co Ltd |
Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
|
MA41629A
(fr)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
|
CA2978226A1
(en)
|
2015-03-04 |
2016-09-09 |
Merck Sharpe & Dohme Corp. |
Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
|
ES2844799T3
(es)
|
2015-04-17 |
2021-07-22 |
Merck Sharp & Dohme |
Biomarcadores sanguíneos de sensibilidad tumoral a antagonistas de PD-1
|
JP6995627B2
(ja)
|
2015-05-19 |
2022-02-04 |
イエール ユニバーシティ |
病的石灰化状態を治療するための組成物およびそれを使用する方法
|
CN107801379B
(zh)
|
2015-06-16 |
2021-05-25 |
卫材R&D管理有限公司 |
抗癌剂
|
EP3325648B1
(de)
|
2015-07-17 |
2023-03-29 |
Illumina, Inc. |
Polymerfolien zur sequenzierung von anwendungen
|
KR20180071299A
(ko)
|
2015-10-18 |
2018-06-27 |
아피메트릭스, 인코포레이티드 |
단일 뉴클레오타이드 다형 및 인델의 다대립유전자 유전자형분석
|
EP3368692B1
(de)
|
2015-10-29 |
2021-07-21 |
Temple University Of The Commonwealth System Of Higher Education |
Modifizierung von 3'-endstücken von nukleinsäuren durch dna-polymerase-theta
|
CA3005142A1
(en)
|
2015-11-20 |
2017-05-26 |
Yale University |
Compositions for treating ectopic calcification disorders, and methods using same
|
JP6824290B2
(ja)
|
2016-05-18 |
2021-02-03 |
イルミナ インコーポレイテッド |
パターン化された疎水性表面を用いる自己組織化パターニング
|
WO2018098241A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Rochester |
Methods of assessing risk of recurrent prostate cancer
|
JP2020517715A
(ja)
|
2017-04-28 |
2020-06-18 |
メルク・シャープ・エンド・ドーム・コーポレイション |
がん療法のためのバイオマーカー
|
US11484543B2
(en)
|
2017-05-18 |
2022-11-01 |
The Rockefeller University |
Compositions and methods for diagnosing and treating diseases and disorders associated with mutant KCNJ5
|
US20200377958A1
(en)
|
2017-12-01 |
2020-12-03 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods for treatment with nae inhibitors
|
EP3728321A1
(de)
|
2017-12-22 |
2020-10-28 |
F. Hoffmann-La Roche AG |
Verwendung von pilra-bindenden mitteln zur behandlung einer erkrankung
|
EP3743728A1
(de)
|
2018-01-25 |
2020-12-02 |
Biogen MA Inc. |
Verfahren zur behandlung von spinaler muskelatrophie
|
GB201803240D0
(en)
|
2018-02-28 |
2018-04-11 |
Synpromics Ltd |
Methods and compositions for enriching nucleic acids
|
WO2020071451A1
(en)
|
2018-10-05 |
2020-04-09 |
Eisai R&D Management Co., Ltd. |
Biomarkers for a therapy comprising a sorafenib compound
|
WO2020071457A1
(en)
|
2018-10-05 |
2020-04-09 |
Eisai R&D Management Co., Ltd. |
Biomarkers for a combination therapy comprising lenvatinib and everolimus
|
US11293061B2
(en)
|
2018-12-26 |
2022-04-05 |
Illumina Cambridge Limited |
Sequencing methods using nucleotides with 3′ AOM blocking group
|
EP3924739A1
(de)
|
2019-02-12 |
2021-12-22 |
Biogen MA Inc. |
Biomarker von progressiver multifokaler leukoenzephalopathie
|
US11421271B2
(en)
|
2019-03-28 |
2022-08-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing using photoswitchable labels
|
GB201916884D0
(en)
|
2019-11-20 |
2020-01-01 |
Evox Therapeutics Ltd |
Nanoparticle-like delivery system
|
MA58991A1
(fr)
|
2020-06-22 |
2023-03-31 |
Illumina Cambridge Ltd |
Nucléosides et nucléotides avec groupe de blocage acétal 3'
|
GB202010278D0
(en)
|
2020-07-03 |
2020-08-19 |
Evox Therapeutics Ltd |
Extracellular vesicles with improved half-life
|
US20220033900A1
(en)
|
2020-07-28 |
2022-02-03 |
Illumina Cambridge Limited |
Substituted coumarin dyes and uses as fluorescent labels
|
EP4236990A1
(de)
|
2020-11-02 |
2023-09-06 |
Simcha Il-18, Inc. |
Interleukin-18-varianten und verfahren zur verwendung
|
US20220195196A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Alkylpyridinium coumarin dyes and uses in sequencing applications
|
US20220195516A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Methods, systems and compositions for nucleic acid sequencing
|
US20220195517A1
(en)
|
2020-12-17 |
2022-06-23 |
Illumina Cambridge Limited |
Long stokes shift chromenoquinoline dyes and uses in sequencing applications
|
US20220195518A1
(en)
|
2020-12-22 |
2022-06-23 |
Illumina Cambridge Limited |
Methods and compositions for nucleic acid sequencing
|
GB2603203A
(en)
|
2021-02-02 |
2022-08-03 |
Univ Heriot Watt |
Method for enriching nucelic acids
|
GB202105925D0
(en)
|
2021-04-26 |
2021-06-09 |
Evox Therapeutics Ltd |
Modified extracellular vesicles (EVs) with improved half-life
|
EP4334327A1
(de)
|
2021-05-05 |
2024-03-13 |
Illumina Cambridge Limited |
Fluoreszierende farbstoffe mit kondensierten bis-bor-heterocyclen und verwendungen in der sequenzierung
|
GB202107182D0
(en)
|
2021-05-19 |
2021-06-30 |
Evox Therapeutics Ltd |
Nanoparticle delivery system for production of engineered extracellular vesicles
|
KR20240009435A
(ko)
|
2021-05-20 |
2024-01-22 |
일루미나, 인코포레이티드 |
합성에 의한 시퀀싱을 위한 조성물 및 방법
|
US20230016633A1
(en)
|
2021-06-15 |
2023-01-19 |
Illumina, Inc. |
Hydrogel-free surface functionalization for sequencing
|
US20230116852A1
(en)
|
2021-07-23 |
2023-04-13 |
Illumina, Inc. |
Methods for preparing substrate surface for dna sequencing
|
WO2023069927A1
(en)
|
2021-10-20 |
2023-04-27 |
Illumina, Inc. |
Methods for capturing library dna for sequencing
|
GB202118946D0
(en)
|
2021-12-23 |
2022-02-09 |
Evox Therapeutics Ltd |
Engineered extracellular vesicles with improved cargo delivery
|
AU2023240337A1
(en)
|
2022-03-22 |
2024-01-18 |
Illumina, Inc. |
Substrate with orthogonally functional nanodomains
|
WO2023186815A1
(en)
|
2022-03-28 |
2023-10-05 |
Illumina Cambridge Limited |
Labeled avidin and methods for sequencing
|
US20230313292A1
(en)
|
2022-03-29 |
2023-10-05 |
Illumina Cambridge Limited |
Chromenoquinoline dyes and uses in sequencing
|
WO2023213979A1
(en)
|
2022-05-06 |
2023-11-09 |
Evox Therapeutics Limited |
Tspan2 as scaffold protein for engineered extracellular vesicles
|
WO2023232829A1
(en)
|
2022-05-31 |
2023-12-07 |
Illumina, Inc |
Compositions and methods for nucleic acid sequencing
|
WO2024003087A1
(en)
|
2022-06-28 |
2024-01-04 |
Illumina, Inc. |
Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
|
GB202210861D0
(en)
|
2022-07-25 |
2022-09-07 |
Univ Oxford Innovation Ltd |
Loaded extracellular vesicle
|
WO2024039516A1
(en)
|
2022-08-19 |
2024-02-22 |
Illumina, Inc. |
Third dna base pair site-specific dna detection
|